Insmed IncorporatedINSMNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P21
Within normal range
vs 2Y Ago
-7.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -32.41% |
| Q3 2025 | -6.28% |
| Q2 2025 | 23.19% |
| Q1 2025 | -34.23% |
| Q4 2024 | -9.83% |
| Q3 2024 | -42.29% |
| Q2 2024 | 31.25% |
| Q1 2024 | -41.92% |
| Q4 2023 | 4.47% |
| Q3 2023 | -9.02% |
| Q2 2023 | 14.71% |
| Q1 2023 | -38.82% |
| Q4 2022 | -19.28% |
| Q3 2022 | 14.06% |
| Q2 2022 | 1.55% |
| Q1 2022 | -25.32% |
| Q4 2021 | -10.85% |
| Q3 2021 | 2.54% |
| Q2 2021 | 39.03% |
| Q1 2021 | -89.53% |
| Q4 2020 | -14.97% |
| Q3 2020 | -57.04% |
| Q2 2020 | 37.58% |
| Q1 2020 | -5.52% |
| Q4 2019 | 14.21% |
| Q3 2019 | 26.13% |
| Q2 2019 | -16.39% |
| Q1 2019 | -4.83% |
| Q4 2018 | -10.32% |
| Q3 2018 | -16.59% |
| Q2 2018 | 21.31% |
| Q1 2018 | -47.04% |
| Q4 2017 | -29.04% |
| Q3 2017 | -5.46% |
| Q2 2017 | 1.73% |
| Q1 2017 | 36.44% |
| Q4 2016 | -81.95% |
| Q3 2016 | -8.41% |
| Q2 2016 | 1.13% |
| Q1 2016 | -7.73% |